145 related articles for article (PubMed ID: 14602525)
1. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
[TBL] [Abstract][Full Text] [Related]
3. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
4. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
[TBL] [Abstract][Full Text] [Related]
5. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
7. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
Alexandrie AK; Nyberg F; Warholm M; Rannug A
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
[TBL] [Abstract][Full Text] [Related]
8. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.
Girdhar Y; Singh N; Behera D; Sharma S
Int J Biol Markers; 2016 Dec; 31(4):e402-e412. PubMed ID: 27396354
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
11. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
19. Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous cell carcinoma.
Han J; Wang L; Yang Y; Zhang J
Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
[TBL] [Abstract][Full Text] [Related]
20. CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Huang FM; Chen HC; Khan MA; Yang FL; Wan XX; Xu AH; Ou-yang FD; Zhang DZ
Med Oncol; 2013 Jun; 30(2):521. PubMed ID: 23471717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
